Sergej Skvortsov
Overview
Explore the profile of Sergej Skvortsov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangesius J, Hormandinger K, Jager R, Skvortsov S, Plankensteiner M, Maffei M, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509257
This study aims to investigate the effect of dose escalation with brachytherapy (BT) as an addition to definitive chemoradiotherapy (CRT) on local control and survival in esophageal cancer. From 2001...
2.
Savic D, Steinbichler T, Ingruber J, Negro G, Aschenbrenner B, Riechelmann H, et al.
Cells
. 2023 Jan;
12(2).
PMID: 36672272
Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising...
3.
Mukha A, Kahya U, Linge A, Chen O, Lock S, Lukiyanchuk V, et al.
Theranostics
. 2021 Aug;
11(16):7844-7868.
PMID: 34335968
Radiotherapy is one of the curative treatment options for localized prostate cancer (PCa). The curative potential of radiotherapy is mediated by irradiation-induced oxidative stress and DNA damage in tumor cells....
4.
Haschka D, Tymoszuk P, Petzer V, Hilbe R, Heeke S, Dichtl S, et al.
JCI Insight
. 2021 Jul;
6(13).
PMID: 34236052
Iron is an essential nutrient for mammals as well as for pathogens. Inflammation-driven changes in systemic and cellular iron homeostasis are central for host-mediated antimicrobial strategies. Here, we studied the...
5.
Aschenbrenner B, Negro G, Savic D, Sorokin M, Buzdin A, Ganswindt U, et al.
Radiol Oncol
. 2021 May;
55(3):305-316.
PMID: 33939900
Background: Statins, small molecular 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, are widely used to lower cholesterol levels in lipid-metabolism disorders. Recent preclinical and clinical studies have shown that statins exert beneficial effects...
6.
Andre F, Frischhut N, Walder A, Skvortsov S, Schmuth M, Nguyen V
J Dtsch Dermatol Ges
. 2020 Jul;
18(7):754-757.
PMID: 32713150
No abstract available.
7.
Andre F, Frischhut N, Walder A, Skvortsov S, Schmuth M, Nguyen V
J Dtsch Dermatol Ges
. 2020 May;
18(7):754-757.
PMID: 32469459
No abstract available.
8.
Negro G, Aschenbrenner B, Brezar S, Cemazar M, Coer A, Gasljevic G, et al.
Radiol Oncol
. 2020 Feb;
54(1):103-118.
PMID: 32061169
Background Metastatic progression of breast cancer is still a challenge in clinical oncology. Therefore, an elucidation how carcinoma cells belonging to different breast cancer subtypes realize their metastatic capacities is...
9.
Steinbichler T, Savic D, Dudas J, Kvitsaridze I, Skvortsov S, Riechelmann H, et al.
Semin Cancer Biol
. 2019 Sep;
60:148-156.
PMID: 31521746
Cancer stem cells (CSC) possess abilities generally associated with embryonic or adult stem cells, especially self-renewal and differentiation, but also dormancy and cellular plasticity that allow adaption to new environmental...
10.
Steinbichler T, Dudas J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I
Mol Cancer
. 2019 Mar;
18(1):58.
PMID: 30925921
Therapy resistance can arise within tumor cells because of genetic or phenotypic changes (intrinsic resistance), or it can be the result of an interaction with the tumor microenvironment (extrinsic resistance)....